Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited)

v3.10.0.1
Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Net sales $ 174,510 $ 154,153 $ 337,480 $ 298,766
Cost of sales 61,492 52,319 116,859 99,064
Gross margin 113,018 101,834 220,621 199,702
Operating expenses:        
Selling, general and administrative 63,603 63,775 130,655 122,064
Research and development 15,812 13,911 30,602 27,459
Total operating expenses 79,415 77,686 161,257 149,523
Operating income 33,603 24,148 59,364 50,179
Other income (expense) (11,836) (2,417) (20,012) (5,480)
Earnings before income taxes 21,767 21,731 39,352 44,699
Income tax expense (benefit) 4,211 (27,116) 4,394 (20,011)
Net earnings 17,556 48,847 34,958 64,710
Other comprehensive income:        
Foreign currency translation adjustments (8,464) 1,524 (9,600) 8,492
Unrealized gain (loss) on derivative instruments - cash flow hedges (3,915) (3,915)
Unrealized gain (loss) on available-for-sale investments (8,582) (16,374)
Other comprehensive (loss) income (12,379) (7,058) (13,515) (7,882)
Comprehensive income $ 5,177 $ 41,789 $ 21,443 $ 56,828
Earnings per share:        
Basic (in dollars per share) $ 0.46 $ 1.30 $ 0.93 $ 1.73
Diluted (in dollars per share) 0.45 1.29 0.90 1.71
Cash dividends per common share: (in dollars per share) $ 0.32 $ 0.32 $ 0.64 $ 0.64
Weighted average common shares outstanding:        
Basic (in shares) 37,766 37,449 37,732 37,412
Diluted (in shares) 38,748 37,926 38,782 37,816